Profits over People: How Big Pharma’s Money Affects Our Health and Wallets

Americans pay the price.
Earlier this month, I posted two articles on Big Pharma, back to back. The first one was my classic approach: How PE Firms Are Flipping Drugs in Price-Gouging Scheme that Cannibalizes the Entire US Economy (with 109 great comments).
The second one was coincidence. The digital ink wasn’t dry on the first article, when its was revealed that the Justice Department was getting antsy: ‘More than a Dozen’ Drugmakers under Criminal Investigation for Price-Fixing, Shares Plunge, after Getting Crushed All Year (56 great comments).
But as always, there’s more to it. Here are some hard numbers from a different angle that shed a lot of light on how the industry works.
By TheLawFirm.com:
Transparency in the pharmaceutical industry is long overdue – but thanks to a new law, these companies are now required to disclose payments made to doctors, teaching hospitals and to various other companies.

This post was published at Wolf Street on November 25, 2016.